Health authorities in the Lazio region of Italy have implemented a specialized Integrated Diagnostic and Therapeutic Pathway (PDTA) to combat diabetic foot, a severe complication of diabetes mellitus. This multidisciplinary approach aims to reduce amputation rates by coordinating care between diabetologists, vascular surgeons, and podiatrists to manage diabetic neuropathy, which affects approximately 30% of patients according to clinical data.
The initiative addresses the critical intersection of glycemic control and peripheral vascular health. By standardizing the “percorso diagnostico terapeutico integrato” (integrated diagnostic-therapeutic pathway), Lazio seeks to move away from fragmented care and toward a centralized model where high-risk patients are identified and treated before ulcers become necrotic. This systemic shift is designed to lower the burden on regional hospitals and improve the long-term quality of life for thousands of residents living with diabetes.
Diabetic foot occurs when a combination of neuropathy—nerve damage that causes loss of sensation—and peripheral artery disease (PAD) restricts blood flow to the lower extremities. According to the World Health Organization, diabetes is a leading cause of non-traumatic lower-limb amputations globally. When a patient cannot feel a small injury due to neuropathy, the resulting ulcer can either fail to heal or become infected, often leading to gangrene if not treated by a specialized team.
The Multidisciplinary Framework of the Lazio Pathway
The Lazio regional health system has structured its pathway around a “team-based” philosophy. Rather than a patient visiting separate clinics, the PDTA integrates several specialties into a single care stream. This prevents the common “referral gap” where a patient might see a primary care physician for a wound but wait weeks to see a vascular specialist to address the underlying blood flow issues.
Central to this model is the classification of risk. Patients are screened using tools to determine their vulnerability to ulceration. Those identified as high-risk are enrolled in a rigorous monitoring program that includes regular podiatric exams, neurological testing of the feet, and vascular ultrasound. This proactive screening is intended to catch “pre-ulcerative” states, where intervention—such as specialized footwear or off-loading devices—can prevent the skin from breaking.
The pathway also emphasizes the role of the “Diabetic Foot Center.” These centers serve as hubs where surgical interventions, such as revascularization (opening blocked arteries), can be performed in close proximity to wound care clinics. This proximity ensures that a surgeon can optimize blood flow to a limb, and a wound care specialist can immediately begin treating the ulcer, significantly increasing the probability of limb salvage.
Managing Diabetic Neuropathy and Vascular Compromise
Diabetic neuropathy is the primary driver of foot complications. In roughly 30% of diabetic patients, the nerves in the extremities degrade, leading to a loss of protective sensation. This means a patient may step on a sharp object or develop a blister without realizing it. Without the “alarm system” of pain, the injury progresses unnoticed.
The Lazio pathway integrates specific diagnostic protocols to identify this nerve damage early. This includes the use of monofilament tests to check tactile sensitivity and tuning forks to assess vibration perception. When neuropathy is detected, the PDTA mandates a shift in patient education, instructing individuals to perform daily visual inspections of their feet—a simple but effective habit that can prevent catastrophic infections.
Parallel to neuropathy is the issue of ischemia. Peripheral artery disease often co-exists with diabetes, narrowing the arteries that supply the feet. According to the American Heart Association, PAD significantly complicates the healing of diabetic ulcers because oxygenated blood cannot reach the damaged tissue. The Lazio pathway utilizes Doppler ultrasound and angiography to map blood flow, allowing surgeons to perform targeted angioplasties or bypass grafts to restore circulation before attempting wound closure.
Impact on Amputation Rates and Public Health
The primary metric for the success of the Lazio PDTA is the reduction of major and minor amputations. Amputations in diabetic patients are rarely the result of a single event but are instead the culmination of neglected wounds and untreated vascular failure. By implementing a standardized pathway, the region aims to shift the curve from “reactive surgery” to “preventative maintenance.”
Public health data indicates that the cost of a single amputation—including the surgery, prolonged hospitalization, and long-term rehabilitation—far exceeds the cost of preventative podiatric care and glycemic management. By investing in the integrated pathway, the Lazio health system reduces the long-term financial strain on the public purse while avoiding the profound psychological and physical trauma associated with limb loss.
Furthermore, the pathway integrates glycemic control as a fundamental pillar of wound healing. Chronic hyperglycemia impairs the function of white blood cells and slows the body’s natural repair mechanisms. The PDTA ensures that the patient’s endocrine specialist is in constant communication with the wound care team, adjusting insulin or oral medications to maintain a glucose range that supports tissue regeneration.
Patient Access and the Role of Primary Care
For the Lazio pathway to function, the “gatekeeper” role of the general practitioner (GP) is vital. The PDTA relies on GPs to identify early warning signs—such as changes in foot temperature, skin color, or the appearance of calluses—and trigger an immediate referral to the specialized foot center. This “fast-track” referral system is designed to bypass traditional bureaucratic delays that often allow a simple ulcer to evolve into a deep-tissue infection.
Patient education is the final component of the strategy. The regional guidelines emphasize that the patient is an active member of the therapeutic team. This includes training on “diabetic-friendly” footwear to avoid friction and the importance of maintaining foot hygiene without over-soaking the skin, which can lead to maceration and further breakdown.
As the region continues to refine this model, the focus remains on expanding access to these specialized centers across both urban and rural areas of Lazio. The goal is to ensure that a patient in a remote village has the same access to a vascular surgeon and a podiatrist as a patient in Rome, thereby eliminating geographic disparities in amputation rates.
Health officials are expected to release updated data on amputation trends and pathway efficacy in upcoming regional health reports. Those living with diabetes in the Lazio region are encouraged to consult their primary care provider to determine if they qualify for the integrated screening program.
Do you have experience with integrated care pathways or a question about diabetic foot prevention? Share your thoughts in the comments below.